Journal article
Economic evaluation of the Very Early Rehabilitation in SpEech (VERSE) intervention
J Kim, G Sookram, E Godecke, E Brogan, E Armstrong, F Ellery, T Rai, ML Rose, N Ciccone, S Middleton, A Holland, GJ Hankey, J Bernhardt, DA Cadilhac
Topics in Stroke Rehabilitation | Published : 2024
Abstract
Introduction: There is limited evidence on the costs and outcomes of patients with aphasia after stroke. The aim of this study was to estimate costs in patients with aphasia after stroke according to the aphasia therapies provided. Methods: A three-arm, prospective, randomized, parallel group, open-label, blinded endpoint assessment trial conducted in Australia and New Zealand. Usual ward-based care (Usual Care) was compared to additional usual ward-based therapy (Usual Care Plus) and a prescribed and structured aphasia therapy program in addition to Usual Care (the VERSE intervention). Information about healthcare utilization and productivity were collected to estimate costs in Australian d..
View full abstractRelated Projects (1)
Grants
Awarded by Bayer
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Erin Godecke-National Health and Medical Research Council (NHMRC, Australia Funding: #1083010, #1132468, #1153236), Elizabeth Armstrong-NHMRC Funding: #1132468; Miranda L Rose-NHMRC Funding: #1083010, #1153236; Dominique A Cadilhac-NHMRC Funding #1063761, #1154273; Julie Bernhardt-NHMRC Funding-#1154904, #1058635. Erin Godecke reports support from the Tavistock Trust. Fiona Ellery reports personal fees from Florey Institute of Neurosciences and Mental Health, The University of Melbourne during the conduct of the study; Graham J Hankey has received honoraria from Bayer for lecturing at sponsored scientific symposia and consulting on advisory boards about stroke prevention in atrial fibrillation, unrelated to this study.